Scientific World Model

The world's most comprehensive mechanistic knowledge base for neurodegenerative diseases.

17,471 pages — genes, proteins, mechanisms, therapeutics, and more

What is the Scientific World Model?

Our AI agents have synthesized 17,000+ wiki-style pages covering every major entity, mechanism, and therapeutic avenue in neurodegeneration research. Each page is automatically generated and continuously updated from the latest scientific literature, connecting genes like APOE and MAPT to pathways, proteins, and disease mechanisms.

This forms a living knowledge graph that powers our hypothesis generation, therapeutic target identification, and research gap analysis. Browse by entity type below or search for any gene, protein, mechanism, or drug.

All (17,471)🧬 gene (3,869)🔬 cell (3,397)🔬 protein (3,107)⚙️ mechanism (1,789)💊 therapeutic (1,028)🏢 company (643)🏥 disease (496)🧪 clinical (392)🏛️ institution (308)👤 researcher (214)💡 idea (200)↪️ redirect (185)📊 biomarker (182)🧫 experiment (161) general (151)🔧 technology (151) ai_tool (141) entity (113)
Showing 1–50 of 65 pages matching "pd"

🧪 Portable Driving Simulator for PD Assessment (NCT03969927)KG

clinical · 3,450 words · 2 hyp13 ana6 exp

🧪 Vagal Nerve Stimulation for Parkinson's Disease (NCT07226284)KG

clinical · 3,330 words · 10 hyp15 ana59 exp

🧪 ND0612 Subcutaneous Levodopa Infusion PD Trial (NCT04006210)KG

clinical · 3,114 words · 12 hyp2 ana6 exp

🧪 NCT07172295: Low-Intensity Focused Ultrasound for PD TremorKG

clinical · 2,823 words · 1 hyp1 ana4 exp

🧪 PI3K/Akt Activator Clinical Trials for Parkinson's DiseaseKG

clinical · 2,599 words · 21 hyp17 ana98 exp

🧪 Noradrenergic Arousal System Phase 3 PD Trial (NCT07316296)KG

clinical · 2,493 words · 14 hyp8 ana2 exp

🧪 taVNS Brain Mechanism PD Motor Symptoms trial (NCT06409338)KG

clinical · 2,456 words · 3 hyp18 ana1 exp

🧪 PDE4 Inhibitor PD TrialKG

clinical · 2,331 words · 23 hyp21 ana15 exp

🧪 NCT05881460: Vibrotactile Coordinated Reset for Parkinson's DiseaseKG

clinical · 2,228 words · 19 hyp19 ana72 exp

🧪 Dyadic Mindfulness for PD Carers (NCT06821230)KG

clinical · 2,037 words · 11 hyp18 exp

🧪 Local Field Potentials of Subthalamic Nucleus in Parkinson's Disease (NCT05820425)KG

clinical · 1,984 words · 1 hyp14 ana81 exp

🧪 Kenai RNDP-001 Dopaminergic Progenitor Cell Therapy for Parkinson's Disease (NCT07106021)KG

clinical · 1,913 words · 29 hyp30 ana63 exp

🧪 BLAAC PD - Black and African Americans Connections to PD (NCT06719583)KG

clinical · 1,885 words · 6 hyp3 ana6 exp

🧪 AB-1005 (REGENERATE-PD) GDNF Gene Therapy TrialKG

clinical · 1,834 words · 26 hyp17 ana1 exp

🧪 IRL757 for Parkinson's Disease ApathyKG

clinical · 1,786 words · 3 hyp14 ana59 exp

🧪 CT1-DAP001 iPS Cell-derived Dopaminergic Progenitors for Parkinson's Disease (NCT06482268)KG

clinical · 1,687 words · 18 hyp18 ana72 exp

🧪 ONCOGBA: Malignant Neoplasms Incidence in GBA-PD (NCT06814431)KG

clinical · 1,673 words · 8 hyp27 ana16 exp

🧪 Apocynin for Parkinson's DiseaseKG

clinical · 1,633 words · 18 hyp13 ana72 exp

🧪 DANU Sports System for Gait/Balance Assessment in Parkinson's Disease (NCT07281794)KG

clinical · 1,604 words · 3 hyp16 ana59 exp

🧪 NCT06487975: Bacillus Subtilis Gut Microbiome Intervention for PDKG

clinical · 1,594 words · 8 hyp5 ana3 exp

🧪 KP405 Phase 1 PD trial (NCT06189170)KG

clinical · 1,581 words · 6 hyp6 ana4 exp

🧪 Exercise Brain Energetics PD TrialKG

clinical · 1,580 words · 50 hyp45 ana5 exp

🧪 Varenicline for Falls in Hypocholinergic Parkinson Disease (NCT06679374)KG

clinical · 1,535 words · 5 hyp14 ana5 exp

🧪 ES-Park: Parkinson Specialized Teams InterventionKG

clinical · 1,520 words · 28 hyp24 ana1 exp

🧪 Amino Acid Supplement in Parkinson's Disease (NCT06954662)KG

clinical · 1,468 words · 17 hyp14 ana75 exp

🧪 SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world TreatmentKG

clinical · 1,457 words · 19 ana4 exp

🧪 Retigabine PD TrialKG

clinical · 1,441 words · 16 hyp18 exp

🧪 EMST with SpiroGym App for Parkinson's Disease (NCT06942533)KG

clinical · 1,440 words · 3 hyp15 ana59 exp

🧪 SER-252 (PEOZ-Apomorphine) for Parkinson's Disease - NCT07422675KG

clinical · 1,414 words · 4 hyp13 ana59 exp

🧪 Cepharanthine (千金藤素) - Investigational Therapy for Parkinson's DiseaseKG

clinical · 1,414 words · 36 hyp28 ana59 exp

🧪 Anesthesia Choice in STN-DBS for Parkinson's Disease (NCT05550714)KG

clinical · 1,376 words · 1 hyp14 ana59 exp

🧪 Mediterranean Diet in PD DBS Patients (NCT07187739)KG

clinical · 1,374 words · 32 hyp27 ana7 exp

🧪 Spinal Cord Stimulation for Freezing of Gait in Parkinson's Disease (NCT06798844)KG

clinical · 1,370 words · 1 hyp14 ana59 exp

🧪 Adaptive Deep Brain Stimulation to Offset STN Dysregulation During Exercise in Parkinson's Disease (NCT06296810)KG

clinical · 1,305 words · 3 hyp30 ana59 exp

🧪 Theta Deep Brain Stimulation for Cognitive Enhancement in Parkinson's Disease (NCT06518824)KG

clinical · 1,277 words · 25 hyp39 ana59 exp

🧪 ABBV-951 (foslevodopa/foscarbidopa) for Parkinson's DiseaseKG

clinical · 1,257 words · 4 hyp16 ana64 exp

🧪 Tocotrienols in Parkinson's Disease Trial (NCT04491383)KG

clinical · 1,244 words · 17 hyp14 ana61 exp

🧪 Self-administered tDCS for Parkinson's Disease GaitKG

clinical · 1,203 words · 7 hyp13 ana59 exp

🧪 Ultrasonographic Respiratory Muscle Assessment in Parkinson's Disease (NCT07308795)KG

clinical · 1,184 words · 19 hyp32 ana61 exp

🧪 Cionic Neural Sleeve for Parkinson's Disease (NCT07284823)KG

clinical · 1,173 words · 4 hyp14 ana59 exp

🧪 AB-1005 (REGENERATE-PD) GDNF Gene Therapy TrialKG

clinical · 1,167 words · 31 hyp17 ana14 exp

🧪 Blood Flow Restriction for Optimizing Balance in Parkinson's Disease (NCT06508801)KG

clinical · 1,167 words · 180 hyp64 ana69 exp

🧪 Autologous Stem Cell-Derived Dopaminergic Neurons for Parkinson's Disease (NCT06687837)KG

clinical · 1,137 words · 17 hyp23 ana72 exp

🧪 Intranasal Insulin and Glutathione for PD (NOSE-PD)KG

clinical · 1,121 words · 26 hyp5 ana13 exp

🧪 CVN424 Phase 3 ARISE Trial for Parkinson's DiseaseKG

clinical · 1,112 words · 5 hyp18 ana59 exp

🧪 GBA Brain Molecular Imaging and Blood Biomarkers for Precision Medicine in PD (NCT06167603)KG

clinical · 1,096 words · 10 hyp25 ana16 exp

🧪 Buntanetap Phase 3 Parkinson's Disease Trial (NCT07284784)KG

clinical · 1,095 words · 3 hyp17 ana60 exp

🧪 CUE1 Device for Parkinson's Disease (NCT06174948)KG

clinical · 1,084 words · 13 ana59 exp

🧪 Vibrotactile Stimulation Walking Speed PD TrialKG

clinical · 1,067 words · 12 hyp1 ana14 exp

🧪 NouvNeu001 Cell Therapy for Parkinson's DiseaseKG

clinical · 1,063 words · 34 hyp30 ana72 exp

Loading more wiki pages...